The ACSO Post: Elacestrant vs Endocrine Monotherapy in Advanced Breast Cancer: Phase III EMERALD Trial Posted on December 12, 2022 at 9:46 am.Shared by contributor Virginia Kaklamani, MD, Medical Oncology, was quoted in this story. Read More Share This Article!